Zobrazeno 1 - 10
of 98
pro vyhledávání: '"Stamboul, Karim"'
Autor:
Fauchier, Laurent, Lecoq, Coralie, Ancedy, Yann, Stamboul, Karim, Saint Etienne, Christophe, Ivanes, Fabrice, Angoulvant, Denis, Babuty, Dominique, Cottin, Yves, Lip, Gregory Y.H.
Publikováno v:
In The American Journal of Cardiology 1 September 2016 118(5):700-707
New insights into symptomatic or silent atrial fibrillation complicating acute myocardial infarction
Autor:
Stamboul, Karim, Fauchier, Laurent, Gudjoncik, Aurelie, Buffet, Philippe, Garnier, Fabien, Lorgis, Luc, Beer, Jean Claude, Touzery, Claude, Cottin, Yves
Publikováno v:
In Archives of Cardiovascular Diseases November 2015 108(11):598-605
Autor:
Goussot, Samuel, Mousson, Christiane, Guenancia, Charles, Stamboul, Karim, Brunel, Philippe, Brunet, Damien, Touzery, Claude, Cottin, Yves, Zeller, Marianne
Publikováno v:
In The American Journal of Cardiology 15 September 2015 116(6):865-871
Autor:
Stamboul, Karim, Zeller, Marianne, Fauchier, Laurent, Gudjoncik, Aurélie, Buffet, Philippe, Garnier, Fabien, Guenancia, Charles, Lorgis, Luc, Beer, Jean Claude, Touzery, Claude, Cottin, Yves
Publikováno v:
In International Journal of Cardiology 1 July 2014 174(3):611-617
Autor:
Lorgis, Luc, Jourda, François, Hachet, Olivier, Zeller, Marianne, Gudjoncik, Aurelie, Dentan, Gilles, Stamboul, Karim, Guenancia, Charles, Mock, Laurent, Cottin, Yves
Publikováno v:
In Heart & Lung - The Journal of Acute and Critical Care September-October 2013 42(5):326-331
Autor:
Stamboul, Karim1,2,3, Zeller, Marianne3, Rochette, Luc3, Cottin, Yves1,2,3, Cochet, Alexandre2, Leclercq, Thibault1, Porot, Guillaume1, Guenancia, Charles1,2,3, Fichot, Marie1, Maillot, Nicolas1, Vergely, Catherine3, Lorgis, Luc1,2,3 luc.lorgis@chu-dijon.fr
Publikováno v:
PLoS ONE. 7/13/2017, Vol. 12 Issue 7, p1-12. 12p.
Autor:
Perrin, Tilman, Mechulan, Alexis, Boveda, Serge, Beganton, Frankie, Defaye, Pascal, Sadoul, Nicolas, Piot, Olivier, Klug, Didier, Gras, Daniel, Perier, Marie-Cécile, Algalarrondo, Vincent, Bordachar, Pierre, Babuty, Dominique, Fauchier, Laurent, Leclercq, Christophe, Marijon, Eloi, Deharo, Jean-Claude, Lecoq, Coralie, Ancedy, Yann, Stamboul, Karim, Saint Etienne, Christophe, Ivanes, Fabrice, Angoulvant, Denis, Cottin, Yves, Lip, Gregory Y.H.
Publikováno v:
American Journal of Cardiology
American Journal of Cardiology, 2016, 118 (5), pp.700-707. ⟨10.1016/j.amjcard.2016.06.018⟩
American Journal of Cardiology, 2016, 118 (5), pp.700-707. ⟨10.1016/j.amjcard.2016.06.018⟩
Management of antithrombotic therapy in patients with atrial fibrillation (AF) and coronary stenting remains challenging, and there is a need for efficient tools to predict their risk of different types of cardiovascular events and death. Several sco
Autor:
Stamboul, Karim1, Lorin, Julie2, Lorgis, Luc1, Guenancia, Charles1, Beer, Jean-Claude1, Touzery, Claude1, Rochette, Luc2, Vergely, Catherine2, Cottin, Yves1, Zeller, Marianne2 Marianne.zeller@u-bourgogne.fr
Publikováno v:
PLoS ONE. 7/9/2015, Vol. 10 Issue 7, p1-12. 12p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fauchier, Laurent, Clementy, Nicolas, Bisson, Arnaud, Stamboul, Karim, Ivanes, Fabrice, Angoulvant, Denis, Babuty, Dominique, Lip, Gregory, Reek, Sven, Burri, Haran, Roberts, Paul, Perings, Christian, Epstein, Andrew, Klein, Helmut, Gorenek, Bulent, Sticherling, Christian, Goette, Andreas, Jung, Werner, Vos, Marc, Brignole, Michele, Elsner, Christian, Dan, Gheorghe-Andrei, Marin, Francisco, Boriani, Giuseppe, Lane, Deirdre, Blomström-Lundqvist, Carina, Savelieva, Irina
Publikováno v:
EP-Europace
EP-Europace, Oxford University Press (OUP): Policy B, 2017, 19 (3), pp.335-345. ⟨10.1093/europace/euw180⟩
Europace, 19(3), 335. Oxford University Press
Europace, Vol. 19, No 3 (2017) pp. 335-345
EP-Europace, Oxford University Press (OUP): Policy B, 2017, 19 (3), pp.335-345. ⟨10.1093/europace/euw180⟩
Europace, 19(3), 335. Oxford University Press
Europace, Vol. 19, No 3 (2017) pp. 335-345
The wearable cardioverter-defibrillator has been available for over a decade and now is frequently prescribed for patients deemed at high arrhythmic risk in whom the underlying pathology is potentially reversible or who are awaiting an implantable ca